Tromethamine: Research, Dosing, and Where to Buy in 2026
A research-first profile for Tromethamine (THAM, tomethamine), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
Tromethamine is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, and 2 transcript dosing protocols for Tromethamine, each linked to its source.
- Also indexed as THAM, tomethamine.
- 2 aggregated dosing-protocol mentions from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is Tromethamine?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
Tromethamine Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
| Speaker | Source | Timestamp | Protocol | Evidence |
|---|---|---|---|---|
| Vigorous Steve | Increase Energy With Lactate Removing Compounds, Carbohydrate... | 00:07:03 | IV administration only | anecdotal |
| VigorousClips | Increase Energy With Lactate Removing Compounds, Carbohydrate... | 00:07:05 | Intravenous administration only; used for maximum lactate clearance; not standard in bodybuilding, typically endurance/cycling context | anecdotal |
Where to Buy Tromethamine in 2026
No tracked vendor recommendations for Tromethamine yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about Tromethamine. Each line links to the original source.
- "In its new formulation as the oral tromethamine salt, fosfomycin has 34 to 41% oral bioavailability, has a mean elimination half-life of 5.7 hours, and is primarily excreted unchanged in the urine." · Patel S et al, 1997 PubMed
- "Bacteriological eradication rates of 75 to 90% were achieved 5 to 11 days after therapy, with eradication rates of 62 to 93% 4 to 6 weeks after therapy." · Patel S et al, 1997 PubMed
- "In 3 large double-blind comparisons with ciprofloxacin, cotrimoxazole and nitrofurantoin, 99% of fosfomycin tromethamine recipients and 100% of patients receiving comparator agents were considered clinically cured or improved after therapy." · Patel S et al, 1997 PubMed
Research and Studies
8 PubMed-indexed papers reference Tromethamine. Top 8 shown.
Legal Status
Tromethamine is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is Tromethamine FDA-approved?
Tromethamine is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
What dosing is reported for Tromethamine?
This page aggregates 2 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.
How much research has been published on Tromethamine?
8 PubMed-indexed paper(s) reference Tromethamine in our current research feed. See the Research and Studies section above for citations.